Purpose: To describe a case of peripapillary pachychoroid syndrome (PPS) in a diabetic patient with cystoid macular edema (CME), treated with intravitreal dexamethasone implant (IDI) injection. This report also illustrates the history of the disease after repeated IDI and dexamethasone topical treatment. Methods: A case report. Results: A 77-year old male patient with PPS and good diabetic control was treated with dexamethasone implant for CME. After an initial morphofunctional improvement associated with a first IDI, the disease relapsed after the second dexamethasone implant injection. This was associated with a significant increase in both intraretinal fluid and choroidal thickness, with subsequent visual acuity (VA) decrease. At this point, a topical dexamethasone treatment was performed and, despite a morphological improvement, VA worsened compared with baseline, likely because of anatomical damage. Conclusion: In this report, the importance of the recognition of PPS is underlined and the possible occurrence of a “rebound” effect due to repeated IDI is described.

Peripapillary pachychoroid syndrome treated with dexamethasone implant: A case report / Feo, A.; La Spina, C.; Romano, M. R.; Querques, G.; Panico, E.; Panico, C.; Del Turco, C.. - In: EUROPEAN JOURNAL OF OPHTHALMOLOGY. - ISSN 1120-6721. - 34:5(2024), pp. NP59-NP64. [10.1177/11206721241254132]

Peripapillary pachychoroid syndrome treated with dexamethasone implant: A case report

Querques G.;
2024

Abstract

Purpose: To describe a case of peripapillary pachychoroid syndrome (PPS) in a diabetic patient with cystoid macular edema (CME), treated with intravitreal dexamethasone implant (IDI) injection. This report also illustrates the history of the disease after repeated IDI and dexamethasone topical treatment. Methods: A case report. Results: A 77-year old male patient with PPS and good diabetic control was treated with dexamethasone implant for CME. After an initial morphofunctional improvement associated with a first IDI, the disease relapsed after the second dexamethasone implant injection. This was associated with a significant increase in both intraretinal fluid and choroidal thickness, with subsequent visual acuity (VA) decrease. At this point, a topical dexamethasone treatment was performed and, despite a morphological improvement, VA worsened compared with baseline, likely because of anatomical damage. Conclusion: In this report, the importance of the recognition of PPS is underlined and the possible occurrence of a “rebound” effect due to repeated IDI is described.
2024
34
5
NP59
NP64
Peripapillary pachychoroid syndrome treated with dexamethasone implant: A case report / Feo, A.; La Spina, C.; Romano, M. R.; Querques, G.; Panico, E.; Panico, C.; Del Turco, C.. - In: EUROPEAN JOURNAL OF OPHTHALMOLOGY. - ISSN 1120-6721. - 34:5(2024), pp. NP59-NP64. [10.1177/11206721241254132]
Feo, A.; La Spina, C.; Romano, M. R.; Querques, G.; Panico, E.; Panico, C.; Del Turco, C.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1404716
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact